All Duke-NUS Medical School articles
-
NewsStudy finds outbreak detection under-resourced in Asia
A two-year assessment provides critical insights and recommendations for strengthening genomic sequencing for infectious disease surveillance in 13 South and Southeast Asian countries.
-
NewsImmune response to dengue can predict risk of severe reinfections
Researchers have found that natural killer T (NKT) cells influence whether the immune response generates protective antibodies that neutralise dengue virus or harmful ones that could exacerbate the disease in future infections.
-
NewsStudy identifies immunity threshold for protection against COVID-19 in children
Researchers have found rather than antibodies, other arms of the immune system – T cells and memory B cells – provide durable protection against symptomatic SARS-CoV-2 infection in children.
-
NewsEpstein-Barr virus hijacks host genome boosting nasopharyngeal carcinoma
Researchers unravel the mechanisms of Epstein-Barr virus (EBV) and host chromatin interactions in nasopharyngeal cancer cells.
-
NewsZika virus vaccine emerges as an unlikely hero in battling brain cancer
Scientists have developed a new approach using the Zika virus to destroy brain cancer cells and inhibit tumour growth, while sparing healthy cells.
-
NewsPotential nasal COVID-19 vaccine candidate offers better and longer protection
Study shows that administering a COVID-19 vaccine as a nasal spray rather than a subcutaneous injection enhances the body’s long-term immune memory, thereby increasing the vaccine’s overall effectiveness.
-
NewsMaternal dengue immunity worsens birth defects caused by Zika virus
A new study finds prior dengue antibodies substantially raise the risk of microcephaly and fetal defects with Zika infection.
-
NewsNewly discovered antibodies can neutralize COVID-19 variants
Scientists have isolated potent neutralizing antibodies from a COVID-19 vaccinated SARS survivor that exhibited remarkable breadth against known sarbecoviruses.
